DTI versus NODDI White Matter Microstructural Biomarkers of Alzheimer's Disease

Kenny Liou1, Sophia I Thomopoulos1, Hannah Yoo1

  • 1Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Insights

Multishell diffusion MRI (dMRI) models like NODDI showed limited advantages over single-shell DTI for detecting Alzheimer's disease (AD) pathology. While NODDI was slightly better for amyloid burden, neither model excelled at identifying cognitive decline or tau pathology.

Area of Science:

  • Neuroimaging
  • Neurodegeneration
  • White Matter Imaging

Background:

  • Diffusion MRI (dMRI) assesses white matter (WM) integrity, crucial in Alzheimer's Disease (AD).
  • Advanced dMRI models using multishell data may offer greater insight into AD-related WM pathology than traditional single-shell methods.
  • The Alzheimer's Disease Neuroimaging Initiative (ADNI) now collects multishell dMRI data.

Purpose of the Study:

  • To compare the sensitivity of single-shell Diffusion Tensor Imaging (DTI) and multishell Neurite Orientation Dispersion and Density Imaging (NODDI) models.
  • To evaluate if multishell NODDI provides deeper insights into WM pathology in AD compared to single-shell DTI.
  • To assess the models' ability to detect key AD indicators: cognitive impairment, amyloid-beta, and tau PET burden.

Main Methods:

  • dMRI data from 533 participants in ADNI3/4 were analyzed.
  • Single-shell DTI and multishell NODDI models were fitted to the dMRI data.
  • Model sensitivity was assessed against clinical cognitive scores and amyloid-beta/tau PET burden.

Main Results:

  • NODDI showed no significant advantage over DTI in detecting cognitive impairment associated with AD.
  • Neither model demonstrated a major advantage in identifying tau PET burden.
  • NODDI exhibited a marginal increase in sensitivity to amyloid-beta PET burden compared to DTI.

Conclusions:

  • Multishell NODDI offers limited additional value over single-shell DTI for assessing cognitive and tau pathologies in AD.
  • NODDI may provide a slight benefit in detecting amyloid pathology in AD.
  • Further research is needed to fully elucidate the utility of advanced dMRI models in AD.